Books Edited:
"Chimeric toxins: Mechanisms of action and therapeutic applications". Lorberboum-Galski H and Luzarovici P (Eds) (2002). Taylor&Francis, New York.
Book Chapters:
1. Ben Ezra, D., Yarkoni, S., Maftzir, G. and Lorberboum-Galski, H. (1998): Cytokines and growth factors. Early gene expression during angiogenic stimuli. In Angiogenesis: Models, Modulators and clinical applications. Maragoudakis ME (Ed.). Plenum Press, New York, pp 349-353.
2. Ben-Yehudah, A. and Lorberboum-Galski, H. (2001). GnRH-based chimeric proteins: future targeting therapy for adenocarcinomas? In "Current Topics in Biochemical Research" Research Trends, 4, 49-59.
3. Lorberboum-Galski. H. (2002). Ligand-receptor interactions studied with chimeric proteins. In "Chimeric toxins: Mechanisms of action and therapeutic applications". Lorberboum-Galski H and Luzarovici P (Eds) Taylor&Francis, New York, pp. 135-147.
4. Ben-Yehudah, A., Belostotsky, R., Aqeilan, R., Azar, Y., Steinberger, I., Fishman, A., Nechushtan, A., Yarkoni, S., and Lorberboum-Galski. H. (2002). Chimeric proteins: a novel approach for eliminating specific cell populations for targeted human therapy.In "Chimeric toxins: Mechanisms of action and therapeutic applications". Lorberboum-Galski H and Luzarovici P (Eds). Taylor&Francis, New York, pp. 148-167.
